CRESCENT BIOPHARMA, INC. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2024-06-30 was $39.38K.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, issued for services for the quarter ending 2024-03-31 was $36.00K.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, issued for services for fiscal 2024 was $75.38K, a 109.38% increase from fiscal 2023.
- CRESCENT BIOPHARMA, INC. stock issued during period, value, issued for services for fiscal 2023 was $36.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2024-12-31 | $75.38K 10-K · filed 2025-02-13 | |
| 2024-06-30 | $39.38K 10-Q · filed 2024-11-13 | |
| 2024-03-31 | $36.00K 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $36.00K 10-K · filed 2025-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |